Case Report
Accepted on 02 Mar 2026
ETV6-NTRK3 as a resistance mechanism to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors: FavorableComplete response after combination of osimertinib and entrectinib: A case report and literature review
in Pharmacology of Anti-Cancer Drugs